Carterra

Salt Lake City, United States Founded: 2004 • Age: 22 yrs Acquired By LJI
SPR-based platforms are developed for enzyme kinetics studies.
Annual revenue - Latest available
Total funding $47.2M 27 rounds
Employees - Tracked headcount
Investors 8 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Carterra

Carterra is a company based in Salt Lake City (United States) founded in 2004 was acquired by LJI in August 2022. Carterra has raised $47.22 million across 27 funding rounds from investors including HHS, PerkinElmer and LJI. Carterra offers products and services including Carterra Ultra, Carterra LSA XT, and Carterra LSA. Carterra operates in a competitive market with competitors including Nicoya Life, Riot Platforms, FOx Biosystems, Pharma Diagnostics and Plasmore, among others.

  • Headquarter Salt Lake City, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Carterra, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $47.22 M (USD)

    in 27 rounds

  • Latest Funding Round
    $5 M (USD), Series A

    Dec 07, 2023

  • Investors
    HHS

    & 7 more

  • Employee Count
    Not available
  • Acquired by
    LJI

    (Aug 01, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Carterra

Carterra offers a comprehensive portfolio of products and services, including Carterra Ultra, Carterra LSA XT, and Carterra LSA.

Product name locked
Category locked
Primary

High-sensitivity platform for fragment and small molecule screening in drug discovery.

Product name locked
Category locked
Locked

Tool for rapid kinetics and weak binder analysis in antibody characterization.

Product name locked
Category locked
Locked

Platform for detailed antibody kinetics and epitope binning processes.

People of Carterra

Headcount 50-200
Employee Profiles 42
Board Members and Advisors 4
Employee Profiles
People
Andrew Hatch
Director of Research
People
Christian Reece
Senior Global Product Manager
People
Steve Chipchase
Chief Production Officer
People
Chris Silva
VP, Marketing

Unlock access to complete

Funding Insights of Carterra

Carterra has successfully raised a total of $47.22M across 27 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Carterra

Carterra has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, PerkinElmer and LJI.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm focused on life science, medical device and healthcare companies
Locked Locked Locked
Expansion capital is provided by Ballast Point Ventures to growing companies.
Locked Locked Locked
Investments are facilitated by Pasadena Angels in Southern California startups.
Locked Locked Locked
Premium access

Investor details for Carterra

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Carterra

Investments
Premium access

Investment portfolio details for Carterra

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Carterra

Premium access

Detailed financials for Carterra

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Carterra Comparisons

Carterra Primary company
Description
SPR-based platforms are developed for enzyme kinetics studie...
Location
Salt Lake City, United States
Founded Year
2004
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Carterra

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Carterra

Carterra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nicoya Life, Riot Platforms, FOx Biosystems, Pharma Diagnostics and Plasmore, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Hyperspectral optical microscopes for surface analysis are provided.
Locked Locked Locked
Bitcoin mining solutions are offered by the platform.
Locked Locked Locked
Developer of fiber optic bio-sensing technology based on surface plasmon resonance
Locked Locked Locked
Biomolecular interactions are analyzed via plate-based LSPR assays.
Locked Locked Locked
Develops nanoplasmon imaging technology
Premium access

Detailed competitors of Carterra

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Carterra

Premium access

Complete news archive for Carterra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Carterra

Carterra was founded in 2004 and raised its 1st funding round 3 years after it was founded.

Carterra is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Carterra is a funded company, having raised a total of $47.22M across 27 funding rounds to date.

Carterra develops SPR based platforms to study enzyme kinetics. The company provides users with instruments and services that enable multiplexing on planar array surfaces. It has developed mAb characterization technology called LSA which is used to study epitope bindingmapping, kinetics, and quantitation. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head.

Carterra's top competitors include Nicoya Life, Riot Platforms and FOx Biosystems.

Carterra offers Carterra Ultra, Carterra LSA XT, and Carterra LSA.

Carterra has 8 investors. Key investors include HHS, PerkinElmer, LJI, Pasadena Angels, and Telegraph Hill Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available